Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Novartis’ iscalimab results hint at extended survival of transplanted organs

pharmatimesJune 11, 2019

Tag: Novartis , iscalimab results , transplanted organs

PharmaSources Customer Service